Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1990-3-9
|
pubmed:abstractText |
A series of cis- and trans-6,6a,7,8,9,10,10a,11-octahydro-11- oxodibenzo[b,e]thiepinacetic acids (6-9) and -oxepinacetic acids (10-13) were prepared and their antiinflammatory activity was examined in the rat carrageenan hind paw edema test. The antiinflammatory activity of these compounds depended on their stereochemical features (C6a, C10a, and C2'). The 6a,10a-trans compounds exhibited considerable antiinflammatory activity, whereas the 6a,10a-cis compounds were inactive. Among the trans compounds, 6,6a,7,8,9,10,10a,11-octahydro-11-oxodibenzo[b,e]thiepin-3-p ropionic acid (9a) and its oxepin analogue (13a) showed an antiinflammatory activity superior to that of indomethacin. The phenethyl ester (25) of 9a showed potent antiinflammatory activity, and its safety index (UD50/ED50) was over 14 times higher than that of indomethacin. The phenethyl ester (25) is the most favorable compound with high antiinflammatory activity and little ulcerogenicity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
504-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2299620-Animals,
pubmed-meshheading:2299620-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:2299620-Carrageenan,
pubmed-meshheading:2299620-Chemical Phenomena,
pubmed-meshheading:2299620-Chemistry,
pubmed-meshheading:2299620-Drug Design,
pubmed-meshheading:2299620-Oxepins,
pubmed-meshheading:2299620-Rats,
pubmed-meshheading:2299620-Rats, Inbred Strains,
pubmed-meshheading:2299620-Structure-Activity Relationship,
pubmed-meshheading:2299620-Thiepins,
pubmed-meshheading:2299620-Ulcer
|
pubmed:year |
1990
|
pubmed:articleTitle |
Synthesis and antiinflammatory activity of cis- and trans-6,6a,7,8,9,10,10a,11-octahydro-11-oxodibenzo[b,e]thiepinacetic and -oxepinacetic acids.
|
pubmed:affiliation |
Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Osaka, Japan.
|
pubmed:publicationType |
Journal Article
|